A Molecular Signature of Myalgia in Myotonic Dystrophy 2
Background: Chronic muscle pain affects close to 20% of the population and is a major health burden. The underlying mechanisms of muscle pain are difficult to investigate as pain presents in patients with very diverse histories. Treatment options are therefore limited and not tailored to underlying...
Main Authors: | Rabih Moshourab, Vinko Palada, Stefanie Grunwald, Ulrike Grieben, Gary R. Lewin, Simone Spuler |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-05-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396416301037 |
Similar Items
-
A Patient with Myotonic Dystrophy Type 1 Presenting as Parkinsonism
by: Ji-Hyun Choi, et al.
Published: (2018-09-01) -
Anesthesia for a Patient with Myotonic Dystrophy
by: Dilek Kalaycı, et al.
Published: (2016-09-01) -
Myotonic Dystrophy: An Anaesthetic Dilemma
by: N Gupta, et al.
Published: (2009-01-01) -
Myotonic Dystrophy: Severity and Maternal Age
by: J Gordon Millichap
Published: (1992-06-01) -
Anesthetic management for a patient with myotonic dystrophy with remimazolam
by: Yasuhiro Morimoto, et al.
Published: (2021-01-01)